Company Analysis

Crescent Biopharma, Inc. (CBIO)

Nasdaq: CBIO · Pharmaceutical Preparations · Waltham, MA · filing with the SEC since 2003
Grade5.1
◀ Past 4.7● Present 4.8▶ Future 5.6
5 est.

Who runs Crescent Biopharma, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Brumm Joshua T
Chief Executive Officer. First filing Jun 2025, latest Sep 18, 2026, 2 filings in all.
Officers reporting now
8
of 16 people with a filing in the last fifteen months
Directors reporting now
8
35 people on the record since 2014
Officerssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Brumm Joshua TChief Executive OfficerJun 2025Sep 18, 20263 · $900,000
Lynch RyanTreasurer, Senior Vice President of Finance and Chief Accounting Officer.Jun 2025Sep 18, 20262 · $0.00
Mcneill JonathanPresident and COOJun 2025Sep 18, 20263 · $400,000
Scalzo Richard WilliamChief Financial OfficerJun 2025Sep 18, 20262 · $0.00
Im Ellie EunkyungChief Medical OfficerJun 2025Sep 18, 20262 · $0.00
Pinkas JanChief Scientific OfficerJul 2025Sep 18, 20262 · $0.00
Bispham Barbara HarlinGeneral Counsel and Corporate Secretary.Jun 2025Sep 18, 20262 · $0.00
Doughty Christopher GrantChief Business OfficerJun 2025Dec 17, 2025none
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
NameRoleFirst filingLatest filingSales, 12 months
Fairmount Funds Management LLCdirectorJun 2025Jul 20, 2026none
Fairmount Healthcare Fund II L.P.directorJun 2025Jul 20, 2026none
Harwin Peter EvandirectorJun 2025Jul 20, 2026none
Kiselak TomasdirectorJun 2025Jul 20, 2026none
Balcom AlexandradirectorJun 2025Jun 3, 2026none
Lubner David CharlesdirectorJun 2025Jun 3, 2026none
Moran SusandirectorJun 2025Jun 3, 2026none
Violin JonathandirectorJun 2025Jun 3, 2026none
Earlier names on the record39, newest filing first
Biotechnology Value Fund II LP · other · last filing Jun 2025Biotechnology Value Fund L P · 10% owner · last filing Jun 2025Biotechnology Value Trading Fund Os LP · other · last filing Jun 2025Bvf Gp Holdings LLC · 10% owner · last filing Jun 2025Bvf I Gp LLC · 10% owner · last filing Jun 2025Bvf II Gp LLC · other · last filing Jun 2025Bvf Inc/il · 10% owner · last filing Jun 2025Bvf Partners L P/il · 10% owner · last filing Jun 2025Bvf Partners Os Ltd. · other · last filing Jun 2025Lampert Mark N · 10% owner · last filing Jun 2025Debbane Raymond · 10% owner · last filing Aug 2024Invus Global Management, LLC · 10% owner · last filing Aug 2024Invus Public Equities Advisors, LLC · 10% owner · last filing Aug 2024Invus Public Equities, L.P. · 10% owner · last filing Aug 2024Siren, L.L.C. · 10% owner · last filing Aug 2024Rock Edwin · officer · last filing Jun 2024Hahn Brian M. · officer · last filing Jun 2024King Rachel K. · officer · last filing May 2024Andrews Patricia S · director · last filing May 2024Goldberg Mark Alan · director · last filing May 2024Jackson Scott Thomas · director · last filing May 2024Junius Daniel M · director · last filing May 2024Koenig Scott · director · last filing May 2024Pearson Timothy R · director · last filing May 2024Semerjian Harout · officer · last filing Jan 2024Johnson Bruce S · officer · last filing Jan 2024Rath Chinmaya · officer · last filing Jan 2024Artal Group S.A. · 10% owner · last filing Feb 2023Artal International Management S.A. · 10% owner · last filing Feb 2023Artal International S.C.A. · 10% owner · last filing Feb 2023Stichting Administratiekantoor Westend · 10% owner · last filing Feb 2023Westend S.A. · 10% owner · last filing Feb 2023Girard Armand · officer · last filing Nov 2022Magnani John L. · officer · last filing Nov 2022Feldman Eric Jay · officer · last filing Mar 2021Thackray Helen M. · officer · last filing Jan 2021Barrett M James · director · last filing May 2018Baldwin John J. · director · last filing Jul 2016Top Franklin H Jr · director · last filing May 2016

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CBIO · research, not advice